Sector Update: Health Care Stocks Lower Premarket Monday

MT Newswires Live

Jan 05

Health care stocks were lower premarket Monday, with the iShares Biotechnology ETF (IBB) slipping 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%.

GH Research (GHRS) shares were up more than 38% after the company said the US Food and Drug Administration has lifted the clinical hold on its investigational new drug application for GH001 as a potential treatment for depression, allowing the company to proceed with subject enrollment in the US.

Novo Nordisk (NVO) stock was up more than 2% after the company said it will offer its 1.5 mg and 4 mg oral weight loss drug Wegovy at $149 per month to self-paying patients in the US, starting Jan. 5.

Gyre Therapeutics (GYRE) shares were nearly 6% higher after the company said its Chinese unit reached an agreement with China's Center for Drug Evaluation to seek conditional approval for its liver fibrosis treatment Hydronidone.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2601875838"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601875838\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601875838?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-05 22:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601875838","market":"sh","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Lower Premarket Monday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were lower premarket Monday, with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) slipping 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%.</p><p>GH Research (GHRS) shares were up more than 38% after the company said the US Food and Drug Administration has lifted the clinical hold on its investigational new drug application for GH001 as a potential treatment for depression, allowing the company to proceed with subject enrollment in the US.</p><p><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> (NVO) stock was up more than 2% after the company said it will offer its 1.5 mg and 4 mg oral weight loss drug Wegovy at $149 per month to self-paying patients in the US, starting Jan. 5.</p><p><a href=\"https://laohu8.com/S/GYRE\">Gyre Therapeutics</a> (GYRE) shares were nearly 6% higher after the company said its Chinese unit reached an agreement with China's Center for Drug Evaluation to seek conditional approval for its liver fibrosis treatment Hydronidone.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Lower Premarket Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Lower Premarket Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-01-05 22:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were lower premarket Monday, with the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) slipping 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%.</p><p>GH Research (GHRS) shares were up more than 38% after the company said the US Food and Drug Administration has lifted the clinical hold on its investigational new drug application for GH001 as a potential treatment for depression, allowing the company to proceed with subject enrollment in the US.</p><p><a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a> (NVO) stock was up more than 2% after the company said it will offer its 1.5 mg and 4 mg oral weight loss drug Wegovy at $149 per month to self-paying patients in the US, starting Jan. 5.</p><p><a href=\"https://laohu8.com/S/GYRE\">Gyre Therapeutics</a> (GYRE) shares were nearly 6% higher after the company said its Chinese unit reached an agreement with China's Center for Drug Evaluation to seek conditional approval for its liver fibrosis treatment Hydronidone.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2601875838","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601875838","pubTimestamp":1767623174,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were lower premarket Monday, with the iShares Biotechnology ETF  slipping 0.3% and the State Street Health Care Select Sector SPDR ETF  down 0.5%.GH Research  shares were up more than 38% after the company said the US Food and Drug Administration has lifted the clinical hold on its investigational new drug application for GH001 as a potential treatment for depression, allowing the company to proceed with subject enrollment in the US.Novo Nordisk  stock was up more than 2% after the company said it will offer its 1.5 mg and 4 mg oral weight loss drug Wegovy at $149 per month to self-paying patients in the US, starting Jan. 5.Gyre Therapeutics  shares were nearly 6% higher after the company said its Chinese unit reached an agreement with China's Center for Drug Evaluation to seek conditional approval for its liver fibrosis treatment Hydronidone.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","BK4532":"文艺复兴科技持仓","BK4599":"减肥药","BK4585":"ETF&股票定投概念","BK4139":"生物科技","NVO":"诺和诺德","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK7104":"黄金","GYRE":"Gyre Therapeutics","GHRS":"GH Research PLC","BK4588":"碎股","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","XBI":"SPDR S&P Biotech ETF","LABU":"三倍做多标普生物-Direxion","BK4007":"制药","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4539":"次新股","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC"},"translate_title":"行业更新：医疗保健股周一盘前走低","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XBI":0.6,"NVO":1.85,"LABU":0.6,"GHRS":1.87,"GYRE":1.83},"content_text":"Health care stocks were lower premarket Monday, with the iShares Biotechnology ETF (IBB) slipping 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.5%.GH Research (GHRS) shares were up more than 38% after the company said the US Food and Drug Administration has lifted the clinical hold on its investigational new drug application for GH001 as a potential treatment for depression, allowing the company to proceed with subject enrollment in the US.Novo Nordisk (NVO) stock was up more than 2% after the company said it will offer its 1.5 mg and 4 mg oral weight loss drug Wegovy at $149 per month to self-paying patients in the US, starting Jan. 5.Gyre Therapeutics (GYRE) shares were nearly 6% higher after the company said its Chinese unit reached an agreement with China's Center for Drug Evaluation to seek conditional approval for its liver fibrosis treatment Hydronidone.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}